Jens Juul Holst
Dr. Holst has pioneered the isolation and characterization of GLP-1 and discovery of the potential of GLP-1 for treatment of diabetes and obesity.
He is an elected member of the Royal Society of Science and Letters, and has received a number of awards including the NovoNordisk Award, the Paul Langerhans Award of the German Diabetes Society, the Knud Lundbæk Award, the KFJ-award of Health Science Faculty of the University of Copenhagen, the Bagger-Sørensen Award and the prestigious Claude Bernard Award of the European Association of the Study of Diabetes.